FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2877598082> ?p ?o ?g. }

• W2877598082 endingPage "e11463" @default.
• W2877598082 startingPage "e11463" @default.
• W2877598082 abstract "To investigate the responses to switching to second-line regimens among patients who had received a long-term first-line antiretroviral therapy. Patients switching to second-line regimens from June 2008 to June 2015 were enrolled from an observational cohort. In addition, patients continuing first-line therapy and had a viral load <1000 copies/mL were included as controls in July 2012. All these patients were followed-up for 36 months or until June 2016. The virological, immunological outcomes, and drug resistance were evaluated. Virological failure was defined as viral load ≥1000 copies/mL after 6 months of treatment since the start of the study. There were 304 patients switching to second-line regimens and 46 patients remaining on first-line therapy enrolled while having received first-line therapy for a median of 7.6 years. Patients with plasma viral load (VL) ≥1000 copies/mL before switching to second-line regimens had a sharp decline in the proportion of virological failure with 26.7%, 20.4%, and 17.0% at 12, 24, and 36 months after regimen switch, respectively (trend test, P < .001). Among these patients, individuals with drug resistance (DR) had a better virological responses as compared with those without DR after regimen switching. While patients with VL <1000 copies/mL at inclusion remained a high rate of viral suppression after switching to second-line regimens. So did patients continuing first-line therapy. Among patients with VL ≥1000 copies/mL before switching to second-line regimens, the rates of drug resistance were decreased from 79.4% at inclusion to 7.5% at 36 months of regimen switch, with the proportion of NRTI- and NNRTI-related drug resistance from 67.2% and 79.4% to 5.4% and 7.5%, respectively. No PI-related resistance was found. Having self-reported missing doses within a month at follow-ups were independently associated with virological failure at 36 months of switching. HIV-infected patients had viral load ≥1000 copies/mL at regimen switch after a long duration of first-line therapy had good virological responses to second-line regimens, especially those harbored drug resistant variants at regimen switch. However, patients with suppressive first-line therapy did not appear to benefit virologically from switching to second-line regimens." @default.
• W2877598082 created "2018-07-19" @default.
• W2877598082 creator A5004196857 @default.
• W2877598082 creator A5025217307 @default.
• W2877598082 creator A5037367122 @default.
• W2877598082 creator A5056053058 @default.
• W2877598082 creator A5058254184 @default.
• W2877598082 creator A5064438008 @default.
• W2877598082 creator A5071778614 @default.
• W2877598082 creator A5076682127 @default.
• W2877598082 creator A5077745456 @default.
• W2877598082 creator A5081590786 @default.
• W2877598082 date "2018-07-01" @default.
• W2877598082 modified "2023-10-14" @default.
• W2877598082 title "Treatment outcomes and HIV drug resistance of patients switching to second-line regimens after long-term first-line antiretroviral therapy" @default.
• W2877598082 cites W1918234658 @default.
• W2877598082 cites W1938727774 @default.
• W2877598082 cites W1973157814 @default.
• W2877598082 cites W1978416331 @default.
• W2877598082 cites W1996256653 @default.
• W2877598082 cites W2011518212 @default.
• W2877598082 cites W2016341196 @default.
• W2877598082 cites W2019644961 @default.
• W2877598082 cites W2020533061 @default.
• W2877598082 cites W2025634036 @default.
• W2877598082 cites W2034414496 @default.
• W2877598082 cites W2034668231 @default.
• W2877598082 cites W2035405666 @default.
• W2877598082 cites W2037720442 @default.
• W2877598082 cites W2038110764 @default.
• W2877598082 cites W2039838339 @default.
• W2877598082 cites W2042014721 @default.
• W2877598082 cites W2042624190 @default.
• W2877598082 cites W2049786616 @default.
• W2877598082 cites W2056118578 @default.
• W2877598082 cites W2070817387 @default.
• W2877598082 cites W2101093607 @default.
• W2877598082 cites W2110784731 @default.
• W2877598082 cites W2110977476 @default.
• W2877598082 cites W2114482418 @default.
• W2877598082 cites W2119658262 @default.
• W2877598082 cites W2127975384 @default.
• W2877598082 cites W2154164013 @default.
• W2877598082 cites W2166121003 @default.
• W2877598082 cites W2168162308 @default.
• W2877598082 cites W2238699416 @default.
• W2877598082 cites W2322196643 @default.
• W2877598082 cites W2414351520 @default.
• W2877598082 cites W2472059781 @default.
• W2877598082 cites W2530548126 @default.
• W2877598082 cites W2622833699 @default.
• W2877598082 cites W2670919236 @default.
• W2877598082 cites W2795657987 @default.
• W2877598082 doi "https://doi.org/10.1097/md.0000000000011463" @default.
• W2877598082 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6076136" @default.
• W2877598082 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29995803" @default.
• W2877598082 hasPublicationYear "2018" @default.
• W2877598082 type Work @default.
• W2877598082 sameAs 2877598082 @default.
• W2877598082 citedByCount "9" @default.
• W2877598082 countsByYear W28775980822019 @default.
• W2877598082 countsByYear W28775980822020 @default.
• W2877598082 countsByYear W28775980822022 @default.
• W2877598082 countsByYear W28775980822023 @default.
• W2877598082 crossrefType "journal-article" @default.
• W2877598082 hasAuthorship W2877598082A5004196857 @default.
• W2877598082 hasAuthorship W2877598082A5025217307 @default.
• W2877598082 hasAuthorship W2877598082A5037367122 @default.
• W2877598082 hasAuthorship W2877598082A5056053058 @default.
• W2877598082 hasAuthorship W2877598082A5058254184 @default.
• W2877598082 hasAuthorship W2877598082A5064438008 @default.
• W2877598082 hasAuthorship W2877598082A5071778614 @default.
• W2877598082 hasAuthorship W2877598082A5076682127 @default.
• W2877598082 hasAuthorship W2877598082A5077745456 @default.
• W2877598082 hasAuthorship W2877598082A5081590786 @default.
• W2877598082 hasBestOaLocation W28775980821 @default.
• W2877598082 hasConcept C114851261 @default.
• W2877598082 hasConcept C126322002 @default.
• W2877598082 hasConcept C140206745 @default.
• W2877598082 hasConcept C142462285 @default.
• W2877598082 hasConcept C203014093 @default.
• W2877598082 hasConcept C2778451633 @default.
• W2877598082 hasConcept C2781413609 @default.
• W2877598082 hasConcept C2993143319 @default.
• W2877598082 hasConcept C2993493390 @default.
• W2877598082 hasConcept C3013748606 @default.
• W2877598082 hasConcept C3019258254 @default.
• W2877598082 hasConcept C500440147 @default.
• W2877598082 hasConcept C71924100 @default.
• W2877598082 hasConcept C86803240 @default.
• W2877598082 hasConcept C89423630 @default.
• W2877598082 hasConceptScore W2877598082C114851261 @default.
• W2877598082 hasConceptScore W2877598082C126322002 @default.
• W2877598082 hasConceptScore W2877598082C140206745 @default.
• W2877598082 hasConceptScore W2877598082C142462285 @default.
• W2877598082 hasConceptScore W2877598082C203014093 @default.
• W2877598082 hasConceptScore W2877598082C2778451633 @default.
• W2877598082 hasConceptScore W2877598082C2781413609 @default.

• next